Last 25 quarters of trend data · Healthcare · Medical Imaging & Radiation
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.94 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.41 | 3.60 | 8.63 | 6.76 | 4.36 | 8.34 | 5.21 | 6.34 | 6.93 | 5.39 | 4.22 | 5.46 | 7.48 | 15.72 | 11.32 | 9.68 | 10.41 | 6.08 | 25.58 | 41.25 | 292.38 |
| — | -56.9% | +65.6% | +6.5% | -37.1% | +54.7% | +23.6% | +16.2% | -7.3% | -65.7% | -62.8% | -43.6% | -28.2% | +158.5% | -55.8% | -76.5% | -96.4% | -98.7% | -94.7% | -92.2% | — | |
| P/B Ratio | 1.25 | 2.70 | 3.67 | 3.07 | 2.25 | 4.26 | 1.60 | 1.26 | 1.31 | 1.35 | 0.92 | 0.95 | 0.95 | 1.56 | 1.48 | 0.91 | 0.48 | 0.42 | 1.04 | 1.49 | 2.74 |
| — | -36.7% | +129.1% | +144.2% | +71.4% | +216.9% | +74.4% | +32.2% | +37.9% | -13.9% | -38.1% | +5.1% | +98.6% | +269.3% | +42.2% | -39.4% | -82.5% | -95.9% | -87.8% | -57.1% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 49.8% | 56.7% | 50.7% | 50.7% | 50.9% | 53.8% | 49.3% | 41.3% | 35.6% | 52.4% | 49.7% | 41.1% | 38.5% | 48.2% | 42.7% | 43.8% | 21.1% | 29.3% | -10.8% | 5.6% | -103.9% |
| — | +5.5% | +3.0% | +22.7% | +43.0% | +2.7% | -0.8% | +0.6% | -7.6% | +8.6% | +16.3% | -6.3% | +82.7% | +64.6% | +496.8% | +687.4% | +120.3% | +132.2% | +61.1% | +106.7% | -9.7% | |
| Operating Margin | -273.4% | -121.8% | -216.9% | -219.3% | -144.9% | -259.5% | -355.9% | -510.2% | -463.8% | -300.9% | -298.7% | -323.2% | -432.9% | -504.7% | -345.8% | -494.7% | -957.1% | -565.7% | -1512.9% | -1575.3% | -5983.3% |
| — | +53.1% | +39.0% | +57.0% | +68.8% | +13.8% | -19.1% | -57.8% | -7.1% | +40.4% | +13.6% | +34.7% | +54.8% | +10.8% | +77.1% | +68.6% | +84.0% | +87.2% | +62.9% | +33.2% | -80.5% | |
| Net Margin | -262.3% | -100.4% | -238.2% | -220.9% | -111.7% | -320.6% | -342.2% | -440.7% | -447.7% | -283.4% | -279.7% | -298.9% | -397.8% | -461.7% | -314.6% | -461.5% | -917.1% | -560.9% | -1506.5% | -1575.7% | -5982.8% |
| — | +68.7% | +30.4% | +49.9% | +75.0% | -13.1% | -22.3% | -47.5% | -12.5% | +38.6% | +11.1% | +35.2% | +56.6% | +17.7% | +79.1% | +70.7% | +84.7% | +87.3% | +63.0% | +33.1% | -80.5% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -79.0% | -17.5% | -26.1% | -22.9% | -17.4% | -35.5% | -23.6% | -20.4% | -19.4% | -16.5% | -14.3% | -12.3% | -12.0% | -10.9% | -9.8% | -10.3% | -10.1% | -9.2% | -14.6% | -13.5% | -20.6% |
| — | +50.9% | -10.9% | -12.0% | +10.0% | -115.3% | -65.3% | -66.1% | -61.4% | -51.2% | -44.8% | -19.7% | -18.8% | -18.3% | +32.4% | +23.7% | +51.0% | +58.4% | -40.8% | -132.0% | -44.1% | |
| ROA | -62.3% | -9.9% | -15.1% | -14.9% | -12.2% | -25.4% | -18.7% | -16.8% | -16.2% | -14.1% | -12.5% | -11.0% | -10.8% | -10.0% | -9.1% | -9.5% | -9.2% | -8.5% | -13.6% | -12.5% | -18.4% |
| — | +61.0% | +19.4% | +11.1% | +24.6% | -79.6% | -49.3% | -53.0% | -49.5% | -41.8% | -38.3% | -15.5% | -17.1% | -17.4% | +33.2% | +23.9% | +49.7% | +56.7% | -36.9% | -124.0% | -91.6% | |
| ROIC | -310.8% | -75.8% | -93.1% | -98.0% | -98.7% | -86.7% | -71.2% | -74.5% | -66.4% | -63.8% | -63.2% | -72.5% | -98.3% | -99.7% | -97.1% | -137.8% | -256.2% | -252.0% | -334.9% | -1314.8% | — |
| — | +12.6% | -30.8% | -31.5% | -48.7% | -35.9% | -12.6% | -2.7% | +32.5% | +36.0% | +34.9% | +47.4% | +61.6% | +60.4% | +71.0% | +89.5% | — | +45.5% | -3019.5% | -22916.0% | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.43 | 0.36 | 0.39 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — | — | — |
| — | +6308.3% | +5285.2% | +6270.2% | +10.3% | +249.5% | +182.7% | +144.1% | +150.2% | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.34 | 5.10 | 6.15 | 5.52 | 4.34 | 3.63 | 5.02 | 6.07 | 6.15 | 6.44 | 8.08 | 9.09 | 10.14 | 11.96 | 13.42 | 14.64 | 14.62 | 11.54 | 15.02 | 15.22 | 12.55 |
| — | +40.6% | +22.6% | -9.0% | -29.5% | -43.6% | -37.9% | -33.3% | -39.3% | -46.2% | -39.8% | -37.9% | -30.6% | +3.7% | -10.7% | -3.8% | +16.5% | +108.8% | -10.6% | +30.1% | -24.4% | |
| Quick Ratio | 3.73 | 4.50 | 5.45 | 4.90 | 3.73 | 3.06 | 4.41 | 5.48 | 5.48 | 5.73 | 7.24 | 8.26 | 9.39 | 11.12 | 12.67 | 13.92 | 14.09 | 11.21 | 14.58 | 14.82 | 12.28 |
| — | +47.2% | +23.6% | -10.8% | -31.9% | -46.7% | -39.1% | -33.6% | -41.6% | -48.5% | -42.9% | -40.7% | -33.4% | -0.9% | -13.0% | -6.1% | +14.8% | +110.6% | -10.9% | +26.7% | -24.2% | |
| Interest Coverage | — | -9.89 | -16.44 | -102.89 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 25 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HYPR stock.
Hyperfine, Inc.'s current P/E is -1.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Hyperfine, Inc.'s current operating margin is -273.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Hyperfine, Inc.'s business trajectory between earnings reports.